C.M. Bidwell & Associates’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-1,675
Closed -$141K – 543
2021
Q4
$141K Hold
1,675
– – 0.09% 214
2021
Q3
$131K Buy
+1,675
New +$139K 0.09% 219
2019
Q3
– Sell
-5,190
Closed -$259K – 423
2019
Q2
$259K Buy
+5,190
New +$219K 0.26% 103

Other funds holding BRKR

C.M. Bidwell & Associates's BRKR Position: Q1 2022 in Review

C.M. Bidwell & Associates sold out of Bruker (BRKR) in Q1 2022, closing a stake of 1,675 shares — an estimated $141K sold.

C.M. Bidwell & Associates first reported a position in BRKR in Q2 2019 and held it in 3 quarters. The position peaked at $259K in Q2 2019. 311 funds tracked by Wall St. Rank hold BRKR as of Q1 2022.

  • C.M. Bidwell & Associates reported no remaining Bruker position as of Q1 2022 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 1,675 Bruker shares in Q1 2022, an estimated $141K.
  • C.M. Bidwell & Associates first reported a position in Bruker in Q2 2019 and held it in 3 quarters.
  • C.M. Bidwell & Associates's Bruker position peaked at $259K in Q2 2019.
  • 311 funds tracked by Wall St. Rank held Bruker as of Q1 2022.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2022, filed 29 Apr 2022.